Drinkable gene therapy foam for the treatment of constrictive esophageal carcinoma.
Saved in:
| Title: | Drinkable gene therapy foam for the treatment of constrictive esophageal carcinoma. |
|---|---|
| Authors: | Stephan SB; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Cummings CL; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Fitzgerald K; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Stephan MT; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. mstephan@fredhutch.org.; Department of Bioengineering and Molecular Engineering & Sciences Institute, University of Washington, Seattle, WA, USA. mstephan@fredhutch.org.; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA. mstephan@fredhutch.org. |
| Source: | Gene therapy [Gene Ther] 2026 Mar; Vol. 33 (2), pp. 118-126. Date of Electronic Publication: 2026 Feb 14. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9421525 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5462 (Electronic) Linking ISSN: 09697128 NLM ISO Abbreviation: Gene Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
